| Application no. and date | 18775644.0 (espacenet) (Federated) (European Patent Register), 20180330 | | Patent/reg. no. and date | DK/EP 3603669, 20240619 | | Publication date | 20200205 | | Priority no. and date | JP 2017070844, 20170331 | | EP pub. no. and date |
EP 3603669 20200205 | | Effective date | | | Applicant/owner | Meiji Seika Pharma Co., Ltd, 4-16, Kyobashi 2-chome Chuo-ku
Tokyo 104-8002, JP,
Dong-A Socio Holdings Co., Ltd., 64, Cheonho-daero
Dongdaemun-gu
Seoul 02587, KR | | Applicant ref. no. | | | Inventor | KAYA, Arpansiree, c/o Meiji Seika Pharma Co. Ltd.
788 Kayama
Odawara-shi
Kanagawa 250-0852, JP,
FUJITA, Michinari, c/o Meiji Seika Pharma Co. Ltd.
788 Kayama
Odawara-shi
Kanagawa 250-0852, JP | | Representative | | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61K 47/18 (2017.01) , A61K 47/26 (2006.01) , A61K 9/08 (2006.01) , A61P 17/06 (2006.01) , A61P 37/02 (2006.01) | | Title | AQUEOUS FORMULATION, AQUEOUS FORMULATION IN INJECTOR, ANTIBODY PROTEIN DISAGGREGATING AGENT, AND ANTIBODY PROTEIN DISAGGREGATION METHOD | | Int. application no. | JP2018013559 | | Int. publication no. | WO2018181876 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
